Share this:

Posted by Center for Individualized Medicine (@samuelsmith5209) · Feb 27, 2014

Implementation of Preemptive Pharmacogenetics


Speaking at the Individualized Medicine Conference in 2013, Mary V. Relling, Pharm.D. examines the clinical practice and implementation on creating the process to preemptively screen for the right drugs for the right patients at the right time.

Dr. Relling is one of the principal investigators within the National Institutes of Health Pharmacogenomics Research Network and co-founder of the Clinical Pharmacogenetics Implementation Consortium.

Clinical Application dna test DNA Testing gene sequencing genome science genomic medicine genomics Implementation Individualized Medicine Mary Relling Mary V Relling personal genomics personalized medicine Pharmacogenetics pharmacogenomics predictive medicine Preemptive


Have something to say? Please login or register to respond.